29
Jun 2026
Scaling organoid workflows with automation and AI for drug discovery
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
29
Jun 2026
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
29
Jun 2026
Discover how AI-driven high-content screening improves 3D imaging, segmentation, and automation.
29
Jun 2026
Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, enhancing personalized therapy.
29
Jun 2026
Obesity trends show significant disparities among demographics, stressing the importance of targeted prevention to address widening health inequalities.
29
Jun 2026
The study finds that greater exposure to daytime light may lower dementia risk, pointing to light's role in enhancing circadian rhythms and cognitive function.
28
Jun 2026
A comparative study of laughter across humans and other great apes found that its regular rhythmic structure may date back around 15 million years. The findings suggest human laughter evolved toward faster, more variable, and more context-sensitive timing, reflecting greater vocal flexibility.
28
Jun 2026
New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men.
28
Jun 2026
Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with manifestations of cytopenias in one, two, or three lineages.
28
Jun 2026
Women with Parkinson's disease may be more vulnerable to Alzheimer's-related changes in the brain than men, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
28
Jun 2026
Women with Parkinson's disease may be more vulnerable to Alzheimer's-related changes in the brain than men, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more